Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123667 · ClinicalTrials.gov registry record
AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)
A clinical trial, sponsored by Chiesi Farmaceutici S.p.A..
- Completed
- Registry status
- 872
- Enrollment target
NCT02123667: Completed study, sponsored by Chiesi Farmaceutici S.p.A..
NCT02123667 is a clinical trial that has completed, run by Chiesi Farmaceutici S.p.A.. The registered enrollment target is 872 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123667 has completed, sponsored by Chiesi Farmaceutici S.p.A..
- COMPLETED
- Registry status
- 872 participants
- Enrollment target
Study Summary
Multinational, multicentre, non-pharmacological intervention, cross-sectional and longitudinal study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 872 participants |
| Start Date | 2014-06-30 |
| Est. Completion | 2017-03-04 |
What the finished NCT02123667 record still lists
NCT02123667 is an observational study that tracks outcomes without assigning an intervention. The registered 872 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02123667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02123667 about?
NCT02123667 is a clinical study titled "AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)". Multinational, multicentre, non-pharmacological intervention, cross-sectional and longitudinal study.
What is the current status of trial NCT02123667?
This trial is currently completed. The enrollment target is 872 participants. The study started on 2014-06-30. Estimated completion is 2017-03-04.
Who is sponsoring clinical trial NCT02123667?
This trial is sponsored by Chiesi Farmaceutici S.p.A., which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI